Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: A mechanism contributing to myocardial remodeling?

Basic Research in Cardiology

Volumn 105, Issue 2, 2010, Pages 219-226

  Conraads, Viviane M ^a   Vrints, Christiaan J ^a   Rodrigus, Inez E ^a   Hoymans, Vicky Y ^a   Van Craenenbroeck, Emeline M ^a   Bosmans, Johan ^a   Claeys, Marc J ^a   Van Herck, Paul ^a   Linke, Axel ^b   Schuler, Gerhard ^b   Adams, Volker ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Atrogenes; Heart failure; Infarction; Remodeling; Ubiquitin proteasome system

Indexed keywords

ATROGIN 1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; MYOSIN HEAVY CHAIN BETA; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; FBXO32 PROTEIN, HUMAN; MUSCLE PROTEIN; PROTEIN KINASE B; TRIM63 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; VENTRICULAR MYOSIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOWN REGULATION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SARCOMERE; SIGNAL TRANSDUCTION; AGED; BIOPSY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BIOPSY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES; VENTRICULAR MYOSINS; VENTRICULAR REMODELING;

EID: 77950365928     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0068-5     Document Type: Article

References (36)

1. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, Rossiello R, Baldi F, Silvestri F, Biasucci LM, Baldi A (2003) Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic postinfarction heart failure. J Am Coll Cardiol 41:753-760
2. Adams V, Linke A, Gielen S, Erbs S, Hambrecht R, Schuler G (2008) Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training. Eur J Cardiovasc Prev Rehabil 15:293-299
3. Adams V, Linke A, Wisloff U, Doring C, Erbs S, Krankel N, Witt CC, Labeit S, Muller-Werdan U, Schuler G, Hambrecht R (2007) Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc Res 73:120-129
4. Anversa P, Olivetti G, Capasso JM (1991) Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68:7D-16D
5. Anversa P, Olivetti G, Li P, Herman MV, Capasso JM (1993) Myocardial, infarction, cardiac anatomy and ventricular loading. Cardioscience 4:55-62 (Pubitemid 23251645)
6. Arya R, Kedar V, Hwang JR, McDonough H, Li HH, Taylor J, Patterson C (2004) Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 167:1147-1159
7. Centner T, Yano J, Kimura E, McElhinny AS, Pelin K, Witt CC, Bang ML, Trombitas K, Granzier H, Gregorio CC, Sorimachi H, Labeit S (2001) Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 306:717-726
8. Condorelli G, Morisco C, Latronico MV, Claudio PP, Dent P, Tsichlis P, Frati G, Drusco A, Croce CM, Napoli C (2002) TNFalpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J 16:1732-1737
9. Depre C, Wang Q, Yan L, Hedhli N, Peter P, Chen L, Hong C, Hittinger L, Ghaleh B, Sadoshima J, Vatner DE, Vatner SF, Madura K (2006) Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 114:1821-1828
10. Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher A (1998) Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells. Circ Res 83:334-341
11. Fang CX, Dong F, Thomas DP, Ma H, He L, Ren J (2008) Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol 295:H1206-H1215
12. Fielitz J, Kim MS, Shelton JM, Latif S, Spencer JA, Glass DJ, Richardson JA, Bassel-Duby R, Olson EN (2007) Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 117:2486-2495
13. Fielitz J, van Rooij E, Spencer JA, Shelton JM, Latif S, van der Nagel R, Bezprozvannaya S, de Windt L, Richardson JA, BasselDuby R, Olson EN (2007) Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc Natl Acad Sci USA 104:4377-4382
14. Glass DJ (2005) Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37:1974-1984
15. Hiraoka E, Kawashima S, Takahashi T, Rikitake Y, Kitamura T, Ogawa W, Yokoyama M (2001) TNF-alpha induces protein synthesis through PI3-kinase-Akt/PKB pathway in cardiac myocytes. Am J Physiol Heart Circ Physiol 280:H1861-H1868
16. Houser SR, Margulies KB (2003) Is depressed myocyte contractility centrally involved in heart failure? Circ Res 92:350-358
17. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen W, Shou Z, Liu P (1999) Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99:1492-1498
18. Kedar V, McDonough H, Arya R, Li HH, Rockman HA, Patterson C (2004) Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci USA 101:18135-18140
19. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627-635
20. Lauten A, Majos E, Mühlich A, Wahlers T, Weider S, Fischer JH, Figulla HR, Bloch W (2009) Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol 104:559-569
21. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114:1058-1071
22. Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, Patterson C (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of forkhead proteins. J Clin Invest 117:3211-3223
23. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988-998
24. Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837-2849
25. Patterson C, Ike C, PWt Willis, Stouffer GA, Willis MS (2007) The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 115:1456-1463
26. Sack MN, Smith RM, Opie LH (2000) Tumor necrosis factor in myocardial hypertrophy and ischaemia: an anti-apoptotic perspective. Cardiovasc Res 45:688-695 (Pubitemid 30047135)
27. Sack M (2002) Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther 94:23-35
28. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K (2006) C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 7:748-754 (Pubitemid 41125888)
29. Schulz R, Heusch G (2009) Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 119:1355-1357
30. Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N (2005) Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitinmediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res 97:418-426
31. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K (2005) The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 280:20814-20823
32. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factoralpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140-146 (Pubitemid 46066782)
33. Vanderheyden M, Mullens W, Delrue L, Goethals M, de Bruyne B, Wijns W, Geelen P, Verstreken S, Wellens F, Bartunek J (2008) Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51:129-136
34. Wallace CK, Stetson SJ, Kucuker SA, Becker KA, Farmer JA, McRee SC, Koerner MM, Noon GP, Torre-Amione G (2005) Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients. J Heart Lung Transplant 24:46-51
35. Wang X, Robbins J (2006) Heart failure and protein quality control. Circ Res 99:1315-1328 (Pubitemid 44949667)
36. Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, Rodriguez JE, Glass D, Patterson C (2009) Muscle ring finger-1 (MuRFl) mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol 296: H997-H1006